Stay updated on Nivolumab for Uterine Cancer - Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The record for a completed Phase 2 study of nivolumab in selected uterine cancer patients is displayed, including eligibility criteria, treatment and outcome details, study locations, and a linked publication and study protocol.
    Difference
    52%
    Check dated 2026-11-08T13:36:14.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:02:04.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added, announcing updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T19:38:06.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:34:05.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:39:49.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study details and navigation, indicating an access or server restriction.
    Difference
    18%
    Check dated 2026-09-20T22:26:12.000Z thumbnail image

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.